Eckburg Paul bought ANTX
March 15, 2024 · Form 4 insider transaction
Eckburg Paul bought 60,000 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderEckburg Paul
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 15, 2024
Filing dateMarch 18, 2024
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.